|
🐜
|
Single-Dose Liposomal Amphotericin B Treatment for Cryptococcal Meningitis
42 auth.
J. Jarvis,
David S. Lawrence,
D. Meya,
E. Kagimu,
J. Kasibante,
Edward Mpoza,
M. Rutakingirwa,
K. Ssebambulidde,
L. Tugume,
Joshua Rhein,
D. Boulware,
H. Mwandumba,
Melanie Moyo,
H. Mzinganjira,
C. Kanyama,
...
M. Hosseinipour,
Chimwemwe Chawinga,
G. Meintjes,
C. Schutz,
K. Comins,
Achita Singh,
C. Muzoora,
Samuel Jjunju,
E. Nuwagira,
M. Mosepele,
T. Leeme,
Keatlaretse Siamisang,
C. Ndhlovu,
A. Hlupeni,
Constantine Mutata,
E. van Widenfelt,
Tao Chen,
Duolao Wang,
W. Hope,
Timothée Boyer-Chammard,
A. Loyse,
S. Molloy,
N. Youssouf,
O. Lortholary,
D. Lalloo,
S. Jaffar,
T. Harrison
|
7 |
2022 |
7
🐜
|
|
🐜
|
Short-course High-dose Liposomal Amphotericin B for Human Immunodeficiency Virus–associated Cryptococcal Meningitis: A Phase 2 Randomized Controlled Trial
19 auth.
J. Jarvis,
T. Leeme,
M. Molefi,
Awilly A. Chofle,
Gabriella Bidwell,
K. Tsholo,
N. Tlhako,
N. Mawoko,
Raju K K Patel,
M. Tenforde,
...
C. Muthoga,
G. Bisson,
Jeremiah Kidola,
J. Changalucha,
David S. Lawrence,
S. Jaffar,
W. Hope,
S. Molloy,
T. Harrison
|
6 |
2018 |
6
🐜
|
|
🐜
|
Advanced Human Immunodeficiency Virus Disease in Botswana Following Successful Antiretroviral Therapy Rollout: Incidence of and Temporal Trends in Cryptococcal Meningitis
23 auth.
M. Tenforde,
M. Mokomane,
T. Leeme,
Raju K K Patel,
Nametso Lekwape,
Chandapiwa Ramodimoosi,
Bonno Dube,
Elizabeth A. Williams,
K. Mokobela,
Ephraim O Tawanana,
...
Tlhagiso Pilatwe,
W. Hurt,
H. Mitchell,
Doreen L Banda,
Hunter H Stone,
M. Molefi,
Kabelo Mokgacha,
H. Phillips,
P. Mullan,
A. Steenhoff,
Y. Mashalla,
M. Mine,
J. Jarvis
|
5 |
2017 |
5
🐜
|
|
🐜
|
High Mortality in HIV-Associated Cryptococcal Meningitis Patients Treated With Amphotericin B–Based Therapy Under Routine Care Conditions in Africa
12 auth.
Raju K K Patel,
T. Leeme,
Caitlin Azzo,
N. Tlhako,
K. Tsholo,
Ephraim O Tawanana,
...
M. Molefi,
M. Mosepele,
David S. Lawrence,
M. Mokomane,
M. Tenforde,
J. Jarvis
|
5 |
2018 |
5
🐜
|
|
🐬
|
HIV-Associated Cryptococcal Meningitis: Bridging the Gap Between Developed and Resource-Limited Settings
M. Tenforde,
Rae Wake,
T. Leeme,
J. Jarvis
|
4 |
2016 |
4
🐬
|
|
🐜
|
AMBITION-cm: intermittent high dose AmBisome on a high dose fluconazole backbone for cryptococcal meningitis induction therapy in sub-Saharan Africa: study protocol for a randomized controlled trial
21 auth.
M. Molefi,
Awilly A. Chofle,
S. Molloy,
S. Kalluvya,
J. Changalucha,
F. Cainelli,
T. Leeme,
Nametso Lekwape,
Drew W. Goldberg,
M. Haverkamp,
...
G. Bisson,
J. Perfect,
E. Letang,
L. Fenner,
G. Meintjes,
R. Burton,
T. Makadzange,
C. Ndhlovu,
W. Hope,
T. Harrison,
J. Jarvis
|
4 |
2015 |
4
🐜
|
|
🐜
|
The Impact of Systematic Point-of-Care Ultrasound on Management of Patients in a Resource-Limited Setting.
15 auth.
Alastair Stanley,
Bahati M K Wajanga,
Hyasinta M Jaka,
R. Purcell,
Lauren M Byrne,
Felicity Williams,
Candace Rypien,
A. Sharpe,
P. Laws,
L. Faustine,
...
T. Leeme,
Emmanuel S Mwabutwa,
R. Peck,
M. Stephens,
D. Kaminstein
|
4 |
2017 |
4
🐜
|
|
🐜
|
Mortality in adult patients with culture-positive and culture-negative meningitis in the Botswana national meningitis survey: a prevalent cohort study
18 auth.
M. Tenforde,
M. Mokomane,
T. Leeme,
N. Tlhako,
K. Tsholo,
Tony Chebani,
Anya Stephenson,
J. Hutton,
H. Mitchell,
Raju K K Patel,
...
W. Hurt,
Tlhagiso Pilatwe,
T. Masupe,
M. Molefi,
B. Guthrie,
C. Farquhar,
M. Mine,
J. Jarvis
|
4 |
2019 |
4
🐜
|
